Journal Title:Advances In Integrative Medicine
The Journal of Advances in Integrative Medicine is renowned for its high standards of scientific publication and rigorous review process. It adopts an international standard double-blind review system to ensure that each manuscript undergoes rigorous review by professional scholars and experts, ensuring the scientific, innovative, and reliable nature of its content. Its publication scope is extensive, covering multiple fields such as traditional Chinese and Western medicine and dietary therapy, joint research between traditional Chinese medicine and Western medicine, the latest developments in precision medicine, and the impact of genomics on disease prevention and treatment. It comprehensively focuses on the full lifecycle management of diseases, including new technologies, methods, and products related to disease occurrence and development, screening and early warning, diagnostic typing, treatment intervention, and prognosis.
In addition, the journal also focuses on the challenges and opportunities in the global health field, as well as the importance of equal access to healthcare for all, and is committed to promoting the development and popularization of integrated medicine on a global scale. Its international editorial team and open access publishing strategy further promote the widespread dissemination and collaborative exchange of academic achievements.
《綜合醫(yī)學的進展雜志》以高標準的科學發(fā)表和嚴格的審稿流程著稱,采用國際標準的雙盲評審制度,確保每篇稿件都經(jīng)過專業(yè)學者和專家的嚴格審核,以保證內容的科學性、創(chuàng)新性和可靠性。其發(fā)表范圍廣泛,涵蓋中西藥與膳食療法、中醫(yī)與西醫(yī)聯(lián)合研究、精準醫(yī)學的最新發(fā)展、基因組學對疾病預防和治療的影響等多個領域,全面關注疾病的全生命周期管理,包括疾病的發(fā)生發(fā)展、篩查預警、診斷分型、治療干預及轉歸預后等方面的新技術、新方法和新產品。
此外,該期刊還關注全球衛(wèi)生領域的挑戰(zhàn)和機遇,以及人人平等享有醫(yī)療保健的重要性,致力于推動綜合醫(yī)學在全球范圍內的發(fā)展與普及。其國際化的編委團隊和開放獲取的出版策略,進一步促進了學術成果的廣泛傳播與合作交流。
Advances In Integrative Medicine由Elsevier出版商出版,收稿方向涵蓋INTEGRATIVE & COMPLEMENTARY MEDICINE全領域,平均審稿速度 15 Weeks ,影響因子指數(shù)1.2,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 28 / 43 |
36% |
按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 30 / 43 |
31.4% |
名詞解釋:
WOS即Web of Science,是全球獲取學術信息的重要數(shù)據(jù)庫,Web of Science包括自然科學、社會科學、藝術與人文領域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術會議多學科內容。給期刊分區(qū)時會按照某一個學科領域劃分,根據(jù)這一學科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結果分別是Q1,Q2,Q3,Q4,Q1代表質量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||
3.2 | 0.329 | 0.493 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻的平均受引用次數(shù)。
SJR:SCImago 期刊等級衡量經(jīng)過加權后的期刊受引用次數(shù)。引用次數(shù)的加權值由施引期刊的學科領域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標準化影響將實際受引用情況對照期刊所屬學科領域中預期的受引用情況進行衡量。
是否OA開放訪問: | h-index: | 年文章數(shù): |
開放 | -- | 19 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
4.17% | 1.2 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
100.00% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務,請聯(lián)系出版商。